Schaefer S
Abteilung Virologie, Institut für Mikrobiologie, Universität Rostock, Rostock, Germany.
J Viral Hepat. 2005 Mar;12(2):111-24. doi: 10.1111/j.1365-2893.2005.00584.x.
Hepatitis B Virus (HBV) genotypes have come of age. The concept that HBV genotypes may influence the course of disease and relevant biological differences has now been recognised. However, there are still major gaps in our knowledge. Most clinical data come from Asia and describe findings in patients infected with genotypes B and C. Large scale studies with genotypes A and D as found in Europe or A, D and E from Africa are urgently needed to broaden our understanding. Experimental data which explain in vivo findings in terms of differences in molecular biology in vitro are still in the beginning. The succeeding years will see many interesting studies which will aid our understanding of how variants and genotypes of HBV influence the spectrum of disease in people infected with HBV.
乙型肝炎病毒(HBV)基因型已步入成熟阶段。HBV基因型可能影响疾病进程及相关生物学差异这一概念现已得到认可。然而,我们的认知仍存在重大差距。大多数临床数据来自亚洲,描述的是感染B型和C型基因型患者的情况。迫切需要针对欧洲发现的A型和D型基因型,或非洲的A型、D型和E型基因型开展大规模研究,以拓宽我们的认知。从体外分子生物学差异角度解释体内研究结果的实验数据仍处于起步阶段。在接下来的几年里,将会有许多有趣的研究,有助于我们理解HBV的变异体和基因型如何影响HBV感染者的疾病谱。